Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study

Autor: Pawełczyk, Tomasz, Grancow-Grabka, Marta, Żurner, Natalia, Pawełczyk, Agnieszka
Zdroj: In Schizophrenia Research April 2021 230:61-68
Databáze: ScienceDirect